File Download
  Patent History
  • Application
    EP 20030753241 2003-10-08
  • Publication
    EP 1562616 2005-08-17
  Patent Family
Supplementary

published patent: FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF

TitleFORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF
Priority Date2003-10-08 PCT/CN2003000843
2002-10-09 US 10/417200P
2003-06-25 US 10/483014P
Inventors
Kumana, Cyrus RustamKwong, YL
Issue Date2005
Citation
EP Published Patent application EP 1562616. European Patent Office (EPO), Escapenet, 2005 How to Cite?
AbstractThe present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.
Persistent Identifierhttp://hdl.handle.net/10722/176742
References

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:25Z-
dc.date.available2012-11-30T08:38:25Z-
dc.date.issued2005-
dc.identifier.citationEP Published Patent application EP 1562616. European Patent Office (EPO), Escapenet, 2005en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176742-
dc.description.abstractThe present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.en_HK
dc.titleFORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOFen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorKumana, Cyrus Rustamen_HK
dc.contributor.inventorKwong, YLen_HK
patents.identifier.applicationEP 20030753241en_HK
patents.description.assigneeUNIV HONG KONG [CN]en_HK
patents.description.countryEuropean Patent Officeen_HK
patents.date.publication2005-08-17en_HK
dc.relation.referencesFR 2786103 (A1) 2000-05-26en_HK
dc.relation.referencesWO 9918798 (A1) 1999-04-22en_HK
dc.relation.referencesXP 000891715en_HK
dc.relation.referencesXP 002194473en_HK
dc.relation.referencesXP 002917127en_HK
dc.relation.referencesCN 1176665 (C) 2004-11-24en_HK
dc.relation.referencesCN 1370540 (A) 2002-09-25en_HK
dc.relation.referencesCN 1285743 (A) 2001-02-28en_HK
patents.identifier.hkutechidMedi-2002-00091-3-
patents.identifier.hkutechidMedi-2002-00091-4-
patents.identifier.hkutechidMedi-2002-00091-5-
patents.identifier.hkutechidMedi-2002-00091-7-
patents.date.application2003-10-08en_HK
patents.date.priority2003-10-08 PCT/CN2003000843en_HK
patents.date.priority2002-10-09 US 10/417200Pen_HK
patents.date.priority2003-06-25 US 10/483014Pen_HK
patents.description.ccEPen_HK
patents.identifier.publicationEP 1562616en_HK
patents.relation.familyAU 2003271510 (A1) 2004-05-04en_HK
patents.relation.familyCN 1723029 (A) 2006-01-18en_HK
patents.relation.familyEP 1562616 (A2) 2005-08-17en_HK
patents.relation.familyJP 2006503109 (A) 2006-01-26en_HK
patents.relation.familyJP 4786341 (B2) 2011-10-05en_HK
patents.relation.familyUS 2004126434 (A1) 2004-07-01en_HK
patents.relation.familyUS 7521071 (B2) 2009-04-21en_HK
patents.relation.familyUS 2008085931 (A1) 2008-04-10en_HK
patents.relation.familyUS 2008089949 (A1) 2008-04-17en_HK
patents.relation.familyUS 2008089951 (A1) 2008-04-17en_HK
patents.relation.familyUS 2008166425 (A1) 2008-07-10en_HK
patents.relation.familyWO 2004032822 (A2) 2004-04-22en_HK
patents.relation.familyWO 2008046299 (A1) 2008-04-24en_HK
patents.relation.familyWO 2008046307 (A1) 2008-04-24en_HK
patents.description.kindA2en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats